Loading provider…
Loading provider…
Ophthalmology Physician in Dallas, TX
NPI: 1144375122HQ Phone
Get MD Karl's Phone NumberMobile
Looking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
TX State Medical License
2009 - 2026
NC State Medical License
2007 - 2013
DC State Medical License
1991 - 2010
MD State Medical License
1990 - 1992

American Board of Ophthalmology
Ophthalmology
University Of Louisville School Of Medicine
louisville.edu
Medical School
Until 1983
Washington University/B-JH/SLCH Consortium
Residency • Ophthalmology
1987 - 1990
Duke University Hospital
Internship • Internal Medicine
1983 - 1984
Authors: Tuo, Jingsheng, Smith, Brena C, Bojanowski, Christine M, Meleth, Annal D, Gery, Igal, Csaky, Karl G, Chew, Emily Y, Chan, Chi-Chao
Journal: FASEB J
Publication Date: 2004-06-18
Clinical classification of age-related macular degeneration.
Authors: Frederick Ferris, C Wilkinson, Alan Bird, Usha Chakravarthy, Emily Chew, Karl Csaky, Srinivas Sadda
Publication Date: 2012-06-26
Authors: Ou, William C, Lesmes, Luis Andres, Christie, Abigail H, Denlar, Renee A, Csaky, Karl G
Journal: Am J Ophthalmol
Publication Date: 2021-01-30
Lead Sponsor: Beacon Therapeutics
Intervention / Treatment: BIOLOGICAL: rAAV2tYF-CB-hRS1
Lead Sponsor: Johns Hopkins University
Collaborators: Juvenile Diabetes Research Foundation, iCo Therapeutics Inc.
Intervention / Treatment: DRUG: Ranibizumab and iCo-007 350 mcg, DRUG: iCo-007 350 mcg, DRUG: iCo-007 700 mcg, DRUG: iCo-007 350 mcg and Laser
Lead Sponsor: Texas Retina Associates
Intervention / Treatment: DRUG: Active bevacizumab and Active dexamethasone, DRUG: Active bevacizumab and Sham dexamethasone